Singulex, CHDI Collaborate on Biomarkers for Huntington's Disease
The partners will develop biomarkers for potential use in drug development targeting the disease.
CHDI Extends Evotec Huntington's Collaboration Through 2017
NEW YORK (GenomeWeb News) – Evotec said today that the CHDI Foundation has extended and expanded the two parties' collaboration on Huntington's disease research through 2017.
Structural Genomics Consortium, CHDI Launch Open-access Huntington's Disease Initiative
NEW YORK (GenomeWeb) – The Structural Genomics Consortium and the CHDI Foundation have struck an agreement to discover and characterize new drug targets for Huntington's disease and to make their findings available for use by academic researchers and pharmaceutical and biotechnology companies.
NEW YORK (GenomeWeb News) – KineMed said this week that it has extended its collaboration with the CHDI Foundation on research into biomarkers for Huntington's disease.
KineMed, CHDI Foundation Extend Huntington's Disease Collaboration
NEW YORK (GenomeWeb) – KineMed and CHDI Foundation today said they are extending their collaboration to characterize and track the pathogenesis of Huntington's disease and to evaluate possible therapeutic interventions.
Aug 14, 2012
GNS, CHDI Partner on Huntington's Disease Model
May 10, 2012
Nov 4, 2010
Apr 29, 2010